Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page. The change does not modify study data, eligibility criteria, or results.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page's revision version was updated from v3.6.0 to v3.6.2, indicating a deployment update with potential minor fixes or improvements not related to the study details.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page adds recruitment status indicating no participants are being sought and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study), while adjusting the Intervention/Treatment header formatting and updating the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check29 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a minor update to the page. This change does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

- Check43 days agoChange DetectedStatus updated to Active, not recruiting, with enrollment reported as 107 and primary completion set for 2026-12. The principal investigator's contact information was removed from the page.SummaryDifference1%

- Check51 days agoChange DetectedThe page revision has been updated to v3.5.4, indicating a backend or rendering system update. No changes to the displayed study information are introduced.SummaryDifference0.1%

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.